News | July 26, 2022
Astec LifeSciences Q1 FY2023 consolidated PAT drops to Rs. 11.39 Cr
The company has reported total income of Rs. 186.97 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 186.97 crores during the period ended June 30, 2022.
The tenure of contract will be upto 10 years from date of signing the contract/installation.
The company has reported total income of Rs. 94.30 crores during the period ended June 30, 2022.
GlaxoSmithKline Pharmaceuticals has reported total income of Rs. 772.71 crores during the period ended June 30, 2022
The product will be manufactured at Lupin's facility in Nagpur, India.
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
Suven Life Sciences has reported total income of Rs. 3.97 crores during the period ended June 30, 2022
Sanofi India has reported total income of Rs. 715 crores during the period ended June 30, 2022.
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
Subscribe To Our Newsletter & Stay Updated
